General Information of the Compound
Compound ID
CP0561945
Compound Name
N-[2-oxo-4-(trifluoromethyl)chromen-7-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide
    Show/Hide
Structure
Formula
C16H8F3N5O3
Molecular Weight
375.266
Canonical SMILES
FC(F)(F)c1cc(=O)oc2cc(NC(=O)c3nc4ncccn4n3)ccc12
    Show/Hide
InChI
InChI=1S/C16H8F3N5O3/c17-16(18,19)10-7-12(25)27-11-6-8(2-3-9(10)11)21-14(26)13-22-15-20-4-1-5-24(15)23-13/h1-7H,(H,21,26)
    Show/Hide
InChIKey
LPJBLOPBEPMVBW-UHFFFAOYSA-N
Physicochemical Property
logP
2.5018
Rotatable Bonds
2
Heavy Atom Count
27
Polar Areas
102.39
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
7
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 1169188
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00894, Androgen receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000141 LNCaP Homo sapiens (Human)  1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS